Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hecker

Showing results (21-30 of 387) with videos related to

Pageof 39
Sort By:
Journal of Bacteriology|August 20, 2004
The ClpP peptidase is the major determinant of bulk protein turnover in Bacillus subtilisHolger Kock, Ulf Gerth, Michael Hecker
Journal of Bacteriology|January 3, 2012
Integration of σB activity into the decision-making process of sporulation initiation in Bacillus subtilisAlexander Reder, Ulf Gerth, Michael Hecker
Expert Review of Proteomics|February 20, 2008
Proteomic signatures uncover thiol-specific electrophile resistance mechanisms in Bacillus subtilisHaike Antelmann, Michael Hecker, Peter Zuber
Annual Review of Microbiology|November 24, 2007
SigB-dependent general stress response in Bacillus subtilis and related gram-positive bacteriaMichael Hecker, Jan Pané-Farré, Uwe Völker
Pharmaceutics|January 26, 2024
Update and Application of a Deep Learning Model for the Prediction of Interactions between Drugs Used by Patients with Multiple SclerosisMichael Hecker, Niklas Frahm, Uwe Klaus Zettl
Autoimmunity Reviews|June 14, 2015
Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patientsBrit Fitzner, Michael Hecker, Uwe Klaus Zettl
Biology of Sex Differences|May 29, 2019
Polypharmacy in patients with multiple sclerosis: a gender-specific analysisNiklas Frahm, Michael Hecker, Uwe Klaus Zettl
Journal of Immunology (Baltimore, Md. : 1950)|April 10, 2019
Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated DiseasesNina Boxberger, Michael Hecker, Uwe K Zettl
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 28, 2003
Proteomics of Staphylococcus aureus--current state and future challengesMichael Hecker, Susanne Engelmann, Stuart J Cordwell
Expert Opinion on Drug Safety|January 23, 2020
Polypharmacy among patients with multiple sclerosis: a qualitative systematic reviewNiklas Frahm, Michael Hecker, Uwe Klaus Zettl
Pageof 39

Showing results (21-30 of 387) with videos related to

Sort By:
Pageof 39
Journal of Bacteriology|August 20, 2004
The ClpP peptidase is the major determinant of bulk protein turnover in Bacillus subtilisHolger Kock, Ulf Gerth, Michael Hecker
Journal of Bacteriology|January 3, 2012
Integration of σB activity into the decision-making process of sporulation initiation in Bacillus subtilisAlexander Reder, Ulf Gerth, Michael Hecker
Expert Review of Proteomics|February 20, 2008
Proteomic signatures uncover thiol-specific electrophile resistance mechanisms in Bacillus subtilisHaike Antelmann, Michael Hecker, Peter Zuber
Annual Review of Microbiology|November 24, 2007
SigB-dependent general stress response in Bacillus subtilis and related gram-positive bacteriaMichael Hecker, Jan Pané-Farré, Uwe Völker
Pharmaceutics|January 26, 2024
Update and Application of a Deep Learning Model for the Prediction of Interactions between Drugs Used by Patients with Multiple SclerosisMichael Hecker, Niklas Frahm, Uwe Klaus Zettl
Autoimmunity Reviews|June 14, 2015
Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patientsBrit Fitzner, Michael Hecker, Uwe Klaus Zettl
Biology of Sex Differences|May 29, 2019
Polypharmacy in patients with multiple sclerosis: a gender-specific analysisNiklas Frahm, Michael Hecker, Uwe Klaus Zettl
Journal of Immunology (Baltimore, Md. : 1950)|April 10, 2019
Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated DiseasesNina Boxberger, Michael Hecker, Uwe K Zettl
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 28, 2003
Proteomics of Staphylococcus aureus--current state and future challengesMichael Hecker, Susanne Engelmann, Stuart J Cordwell
Expert Opinion on Drug Safety|January 23, 2020
Polypharmacy among patients with multiple sclerosis: a qualitative systematic reviewNiklas Frahm, Michael Hecker, Uwe Klaus Zettl
Pageof 39